DOCSLIB.ORG

Treatment for Fatigue in Multiple Sclerosis 27 No

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Treatment for Fatigue in Multiple Sclerosis 27 No Health Technology Assessment 2000; Vol. 4: No. 27 Rapid review Treatments for fatigue in multiple sclerosis: a rapid and systematic review P Brañas R Jordan A Fry-Smith A Burls C Hyde Health Technology Assessment NHS R&D HTA Programme HTA Standing Group on Health Technology Current members Chair: Professor John Gabbay Dr Jeremy Metters Dr John Tripp Professor Kent Woods Director, Wessex Institute Deputy Chief Medical Officer, Senior Lecturer in Child Professor of Therapeutics, for Health Research Department of Health Health, Royal Devon and Exeter University of Leicester & Development Professor Maggie Pearson Healthcare NHS Trust Regional Director of R&D, Professor Sir John Professor Tom Walley Professor Martin Buxton NHS Executive North West Grimley Evans Director, Director & Professor of Professor of Clinical Geratology, Mr Hugh Ross Prescribing Research Group, Health Economics, Radcliffe Infirmary, Chief Executive, University of Liverpool Health Economics Oxford The United Bristol Research Group, Healthcare NHS Trust Dr Julie Woodin Brunel University Dr Tony Hope Professor Trevor Sheldon Clinical Reader in Medicine, Chief Executive, Professor Shah Ebrahim Joint Director, York Health Nuffield Department of Nottingham Health Authority Professor of Epidemiology Policy Group, University of York Clinical Medicine, of Ageing, University of Bristol University of Oxford Professor Mike Smith Professor Francis H Creed Faculty Dean of Research Professor of Professor Richard Lilford for Medicine, Dentistry, Psychological Medicine, Regional Director of R&D, Psychology & Health, Manchester Royal Infirmary NHS Executive West Midlands University of Leeds Past members Professor Sir Miles Irving* Professor John Farndon Professor Michael Maisey Professor Martin Roland Professor of Surgery, Professor of Surgery, Professor of Professor of General Practice, University of Manchester, University of Bristol Radiological Sciences, University of Manchester Hope Hospital, Salford Professor Charles Florey Guy’s, King’s & St Thomas’s School of Medicine & Dentistry, Professor Ian Russell Department of Epidemiology Dr Sheila Adam London Department of Health Sciences Department of Health & Public Health, Ninewells & Clinical Evaluation, Hospital & Medical School, Mrs Gloria Oates University of York Professor Angela Coulter University of Dundee Chief Executive, Director, King’s Fund, Professor Howard Oldham NHS Trust Dr Charles Swan London Glennester Consultant Gastroenterologist, North Staffordshire Professor of Social Science Dr George Poste Royal Infirmary Professor Anthony Culyer & Administration, London Chief Science & Technology Deputy Vice-Chancellor, School of Economics & Officer, SmithKline Beecham University of York Political Science Professor Michael Rawlins Dr Peter Doyle Mr John H James Wolfson Unit of Executive Director, Zeneca Ltd, Chief Executive, Clinical Pharmacology, ACOST Committee on Medical Kensington, Chelsea & University of Newcastle- Research & Health Westminster Health Authority upon-Tyne * Previous Chair Details of the membership of the HTA panels, the NCCHTA Advisory Group and the HTA Commissioning Board are given at the end of this report. HTA How to obtain copies of this and other HTA Programme reports. An electronic version of this publication, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (http://www.hta.ac.uk). A fully searchable CD-ROM is also available (see below). Printed copies of HTA monographs cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our Despatch Agents. Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph. You can order HTA monographs from our Despatch Agents: – fax (with credit card or official purchase order) – post (with credit card or official purchase order or cheque) – phone during office hours (credit card only). Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. Contact details are as follows: HTA Despatch Email: [email protected] c/o Direct Mail Works Ltd Tel: 02392 492 000 4 Oakwood Business Centre Fax: 02392 478 555 Downley, HAVANT PO9 2NP, UK Fax from outside the UK: +44 2392 478 555 NHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30–40 titles). The commercial subscription rate is £300 per volume. Please see our website for details. Subscriptions can only be purchased for the current or forthcoming volume. Payment methods Paying by cheque If you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit card The following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase order You can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD? Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide. The website also provides information about the HTA Programme and lists the membership of the various committees. Treatments for fatigue in multiple sclerosis: a rapid and systematic review P Brañas R Jordan A Fry-Smith A Burls C Hyde* West Midlands Development and Evaluation Service, The University of Birmingham, Birmingham, UK * Corresponding author Competing interests: none declared Published October 2000 This report should be referenced as follows: Brañas P,Jordan R, Fry-Smith A, Burls A, Hyde C.Treatments for fatigue in multiple sclerosis: a rapid and systematic review. Health Technol Assess 2000;4(27). Health Technology Assessment is indexed in Index Medicus/MEDLINE and Excerpta Medica/ EMBASE. Copies of the Executive Summaries are available from the NCCHTA website (see overleaf). NHS R&D HTA Programme he overall aim of the NHS R&D Health Technology Assessment (HTA) programme is to ensure T that high-quality research information on the costs, effectiveness and broader impact of health technologies is produced in the most efficient way for those who use, manage and work in the NHS. Research is undertaken in those areas where the evidence will lead to the greatest benefits to patients, either through improved patient outcomes or the most efficient use of NHS resources. The Standing Group on Health Technology advises on national priorities for health technology assessment. Six advisory panels assist the Standing Group in identifying and prioritising projects. These priorities are then considered by the HTA Commissioning Board supported by the National Coordinating Centre for HTA (NCCHTA). The research reported in this monograph was commissioned by the HTA programme (project number 99/05/05) on behalf of the National Institute for Clinical Excellence (NICE). Rapid reviews are completed in a limited time to inform the appraisal and guideline development processes managed by NICE. The review brings together evidence on key aspects of the use of the technology concerned. However, appraisals and guidelines produced by NICE are informed by a wide range of sources. Any views expressed in this rapid review are therefore those of the authors and not necessarily those of the HTA programme, NICE or the Department of Health. Reviews in Health Technology Assessment are termed ‘systematic’ when the account of the search, appraisal and synthesis methods (to minimise biases and random errors) would, in theory, permit the replication of the review by others. Criteria for inclusion in the HTA monograph series Reports are published in the HTA monograph series if (1) they have resulted from work either prioritised by the Standing Group on Health Technology, or otherwise commissioned for the HTA programme, and (2) they are of a sufficiently high scientific quality as assessed by the referees and editors. Series Editors: Andrew Stevens, Ken Stein and John Gabbay Monograph Editorial Manager: Melanie Corris The editors and publisher have tried to ensure the accuracy of this report but do not accept liability for damages or losses arising from material published in this report. ISSN 1366-5278 © Crown copyright 2000 Enquiries relating to copyright should be addressed to the NCCHTA (see address given below). Published by Core Research, Alton, on behalf of the NCCHTA. Printed on acid-free paper in the UK by The Basingstoke Press, Basingstoke. Copies of this report can be obtained from: The National Coordinating Centre for Health Technology Assessment, Mailpoint 728, Boldrewood, University of Southampton, Southampton, SO16 7PX, UK. Fax: +44 (0) 23 8059 5639 Email: [email protected] http://www.ncchta.org Health Technology Assessment 2000; Vol. 4: No. 27 Contents List of abbreviations and glossary ............. i 4 Discussion ...................................................... 37 Importance of fatigue in MS ......................... 37 Executive summary .................................... iii Effects and effectiveness of treatment to alleviate fatigue in MS ..................................
Load more

Recommended publications
  • Economic Evaluation of a Primary Care-Based Education Programme for Patients with Osteoarthritis of the Knee
    Health Technology Assessment 1999; Vol. 3: No. 23 Economic evaluation of a primary care-based education programme for patients with osteoarthritis of the knee J Lord C Victor P Littlejohns FM Ross JS Axford Health Technology Assessment NHS R&D HTA Programme HTA Standing Group on Health Technology Current members Chair: Professor John Gabbay Dr Jeremy Metters Dr John Tripp Professor Kent Woods Director, Wessex Institute Deputy Chief Medical Officer, Senior Lecturer in Child Health, Professor of Therapeutics, for Health Research Department of Health Royal Devon and Exeter University of Leicester & Development Professor Maggie Pearson Healthcare NHS Trust Regional Director of R&D, Professor Sir John Professor Tom Walley Professor Martin Buxton NHS Executive North West Grimley Evans Director, Director & Professor of Professor of Clinical Geratology, Mr Hugh Ross Prescribing Research Group, Health Economics, Radcliffe Infirmary, Chief Executive, University of Liverpool Health Economics Oxford The United Bristol Research Group, Healthcare NHS Trust Dr Julie Woodin Brunel University Dr Tony Hope Professor Trevor Sheldon Clinical Reader in Medicine, Chief Executive, Professor Shah Ebrahim Joint Director, York Health Nuffield Department of Nottingham Health Authority Professor of Epidemiology Policy Group, University of York Clinical Medicine, of Ageing, University of Bristol University of Oxford Professor Mike Smith Professor Francis H Creed Faculty Dean of Research Professor of Professor Richard Lilford for Medicine, Dentistry, Psychological
    [Show full text]
  • Autologous Chondrocyte Implantation for Cartilage Defects in Knee Joints ISSN 1366-5278 Feedback Your Views About This Report
    Health Technology Assessment Health Technology Health Technology Assessment 2005; Vol. 9: No. 47 2005; 9: No. 47 Vol. Autologous chondrocyte implantation for cartilage defects in knee joints Clinical and cost-effectiveness of autologous chondrocyte implantation for cartilage defects in knee joints: systematic review and economic evaluation C Clar, E Cummins, L McIntyre, S Thomas, Feedback J Lamb, L Bain, P Jobanputra and N Waugh The HTA Programme and the authors would like to know your views about this report. The Correspondence Page on the HTA website (http://www.ncchta.org) is a convenient way to publish your comments. If you prefer, you can send your comments to the address below, telling us whether you would like us to transfer them to the website. We look forward to hearing from you. December 2005 The National Coordinating Centre for Health Technology Assessment, Mailpoint 728, Boldrewood, Health Technology Assessment University of Southampton, NHS R&D HTA Programme Southampton, SO16 7PX, UK. HTA Fax: +44 (0) 23 8059 5639 Email: [email protected] http://www.ncchta.org ISSN 1366-5278 HTA How to obtain copies of this and other HTA Programme reports. An electronic version of this publication, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (http://www.ncchta.org). A fully searchable CD-ROM is also available (see below). Printed copies of HTA monographs cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our Despatch Agents, York Publishing Services. Non-UK purchasers will have to pay a small fee for post and packing.
    [Show full text]
  • A Randomised Controlled Trial of Larval Therapy in the Management of Leg Ulcers
    This is a repository copy of VenUS II : a randomised controlled trial of larval therapy in the management of leg ulcers. White Rose Research Online URL for this paper: https://eprints.whiterose.ac.uk/75220/ Version: Published Version Article: Dumville, J. C., Worthy, G., Soares, M. O. orcid.org/0000-0003-1579-8513 et al. (8 more authors) (2009) VenUS II : a randomised controlled trial of larval therapy in the management of leg ulcers. Health technology assessment. pp. 1-220. ISSN 2046-4924 https://doi.org/10.3310/hta13550 Reuse Items deposited in White Rose Research Online are protected by copyright, with all rights reserved unless indicated otherwise. They may be downloaded and/or printed for private study, or other acts as permitted by national copyright laws. The publisher or other rights holders may allow further reproduction and re-use of the full text version. This is indicated by the licence information on the White Rose Research Online record for the item. Takedown If you consider content in White Rose Research Online to be in breach of UK law, please notify us by emailing [email protected] including the URL of the record and the reason for the withdrawal request. [email protected] https://eprints.whiterose.ac.uk/ Health Technology Assessment 2009; Vol. 13: No. 55 VenUS II: a randomised controlled trial of larval therapy in the management of leg ulcers JC Dumville, G Worthy, MO Soares, JM Bland, N Cullum, C Dowson, C Iglesias, D McCaughan, JL Mitchell, EA Nelson and DJ Torgerson on behalf of the VenUS II team November 2009 DOI: 10.3310/hta13550 Health Technology Assessment NIHR HTA programme www.hta.ac.uk HTA How to obtain copies of this and other HTA programme reports An electronic version of this publication, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (www.hta.ac.uk).
    [Show full text]
  • No Need for Metadata Here
    Evaluation of patient reporting of adverse drug reactions to the UK ‘Yellow Card Scheme’: literature review, descriptive and qualitative analyses, and questionnaire surveys AJ Avery,1* C Anderson,1 CM Bond,2 H Fortnum,1 A Gifford,3 PC Hannaford,2 L Hazell,4 J Krska,5 AJ Lee,2 DJ McLernon,2 E Murphy,6 S Shakir4 and MC Watson2 1University of Nottingham, Nottingham, UK 2University of Aberdeen, Aberdeen, UK 3Keele University, Keele, Newcastle-under-Lyme, UK 4Drug Safety Research Unit, Southampton, Southampton, UK 5Liverpool John Moores University, Liverpool, UK 6University of Leicester, Leicester, UK *Corresponding author Declared competing interests of authors: none Published April 2011 DOI: 10.3310/hta15200 This report should be referenced as follows: Avery AJ, Anderson C, Bond CM, Fortnum H, Gifford A, Hannaford PC, et al. Evaluation of patient reporting of adverse drug reactions to the UK ‘Yellow Card Scheme’: literature review, descriptive and qualitative analyses, and questionnaire surveys. Health Technol Assess 2011;15(20). Health Technology Assessment is indexed and abstracted in Index Medicus/MEDLINE, Excerpta Medica/EMBASE, Science Citation Index Expanded (SciSearch) and Current Contents/ Clinical Medicine. ii NIHR Health Technology Assessment programme The Health Technology Assessment (HTA) programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. ‘Health technologies’ are broadly defined as all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care.
    [Show full text]
  • Aggressive Versus Symptomatic Therapy in Established Rheumatoid Arthritis ISSN 1366-5278 Feedback Your Views About This Report
    Health Technology Assessment Health Technology Health Technology Assessment 2005; Vol. 9: No. 34 2005; 9: No. 34 Vol. Aggressive versus symptomatic therapy in established rheumatoid arthritis The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis Feedback D Symmons, K Tricker, C Roberts, L Davies, The HTA Programme and the authors would like to know P Dawes and DL Scott your views about this report. The Correspondence Page on the HTA website (http://www.ncchta.org) is a convenient way to publish your comments. If you prefer, you can send your comments to the address below, telling us whether you would like us to transfer them to the website. We look forward to hearing from you. September 2005 The National Coordinating Centre for Health Technology Assessment, Mailpoint 728, Boldrewood, Health Technology Assessment University of Southampton, NHS R&D HTA Programme Southampton, SO16 7PX, UK. HTA Fax: +44 (0) 23 8059 5639 Email: [email protected] http://www.ncchta.org ISSN 1366-5278 HTA How to obtain copies of this and other HTA Programme reports. An electronic version of this publication, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (http://www.hta.ac.uk). A fully searchable CD-ROM is also available (see below). Printed copies of HTA monographs cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our Despatch Agents. Non-UK purchasers will have to pay a small fee for post and packing.
    [Show full text]
  • A Randomised Controlled Trial of Post-Operative Radiotherapy Following Breast-Conserving Surgery in a Minimum-Risk Population
    Health Technology Assessment 2011; Vol. 15: No. 12 ISSN 1366-5278 A randomised controlled trial of post-operative radiotherapy following breast-conserving surgery in a minimum-risk population. Quality of life at 5 years in the PRIME trial LJ Williams, IH Kunkler, CC King, W Jack and M van der Pol March 2011 10.3310/hta15120 Health Technology Assessment NIHR HTA programme www.hta.ac.uk HTA How to obtain copies of this and other HTA programme reports An electronic version of this title, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (www.hta.ac.uk). A fully searchable DVD is also available (see below). Printed copies of HTA journal series issues cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our despatch agents. Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per issue and for the rest of the world £3 per issue. How to order: – fax (with credit card details) – post (with credit card details or cheque) – phone during office hours (credit card only). Additionally the HTA website allows you to either print out your order or download a blank order form. Contact details are as follows: Synergie UK (HTA Department) Email: [email protected] Digital House, The Loddon Centre Tel: 0845 812 4000 – ask for ‘HTA Payment Services’ Wade Road (out-of-hours answer-phone service) Basingstoke Hants RG24 8QW Fax: 0845 812 4001 – put ‘HTA Order’ on the fax header Payment methods Paying by cheque If you pay by cheque, the cheque must be in pounds sterling, made payable to University of Southampton and drawn on a bank with a UK address.
    [Show full text]
  • Accuracy of Bacterial DNA Testing for Central Venous Catheter-Associated Bloodstream Infection in Children with Cancer
    Health Technology Assessment 2011; Vol. 15: No.71 Rationale Health Technology Assessment 2011; Vol. 15: No. 7 AbstractMethods Results GlossaryConclusions ChapterList of abbreviations 6 Discussion ExecutiveMain findings summary StudyBackground limitations ImplicationsObjectives for practice RecommendationsMethods for research Results AcknowledgementsConclusions Accuracy of bacterial DNA testing for ContributionRecommendations of authors for research Trial registration central venous catheter-associated ReferencesFunding bloodstream infection in children with ChapterAppendix 1 1 ProtocolBackground for the and accuracy rationale study (Chapter 2) cancer SynopsisChildren with cancer Diagnosis of central venous catheter-associated infection AppendixRationale 2 for the study DataOverview collection of the sheets study (accuracy study, Chapter 2) M Millar, W Zhou, R Skinner, B Pizer, ChapterAppendix 2 3 E Hennessy, M Wilks and RE Gilbert PrognosticAccuracy markers of DNA for testing sequelae for centralof central venous venous catheter-associated catheter-associated bloodstream infection in infection:children 6-month with cancer follow-up period (Chapter 3) Introduction Appendix 4 Methods Slow infusion versus bolus infection for treating suspected central venous catheter- Results associated infection (Chapter 4) Discussion Appendix 5 ChapterSearch 3 terms for the systematic review (Chapter 4) Prognostic markers for sequelae of central venous catheter-associated Search for papers on prognosis bloodstream infection Cochrane Central Register of
    [Show full text]
  • The Causes and Effects of Socio-Demographic Exclusions from Clinical Trials ISSN 1366-5278 Feedback Your Views About This Report
    Health Technology Assessment Health Technology Health Technology Assessment 2005; Vol. 9: No. 38 2005; 9: No. 38 Vol. The causes and effects of socio-demographic exclusions from clinical trials The causes and effects of socio-demographic exclusions from clinical trials C Bartlett, L Doyal, S Ebrahim, P Davey, M Bachmann, M Egger and P Dieppe Feedback The HTA Programme and the authors would like to know your views about this report. The Correspondence Page on the HTA website (http://www.ncchta.org) is a convenient way to publish your comments. If you prefer, you can send your comments to the address below, telling us whether you would like us to transfer them to the website. We look forward to hearing from you. October 2005 The National Coordinating Centre for Health Technology Assessment, Mailpoint 728, Boldrewood, Health Technology Assessment University of Southampton, NHS R&D HTA Programme Southampton, SO16 7PX, UK. HTA Fax: +44 (0) 23 8059 5639 Email: [email protected] http://www.ncchta.org ISSN 1366-5278 HTA How to obtain copies of this and other HTA Programme reports. An electronic version of this publication, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (http://www.hta.ac.uk). A fully searchable CD-ROM is also available (see below). Printed copies of HTA monographs cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our Despatch Agents. Non-UK purchasers will have to pay a small fee for post and packing.
    [Show full text]
  • For the Treatment of Rheumatoid Arthritis M Connock, S Tubeuf, K Malottki, a Uthman, J Round, S Bayliss, C Meads and D Moore
    This is a repository copy of Bevacizumab in combination with fluoropyrimidine-based chemotherapy for the first-line treatment of metastatic colorectal cancer . White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/43321/ Article: Whyte, S., Pandor, A., Stevenson, M. et al. (1 more author) (2010) Bevacizumab in combination with fluoropyrimidine-based chemotherapy for the first-line treatment of metastatic colorectal cancer. Health Technology Assessment , 14 (2). pp. 47-53. ISSN 1366-5278 https://doi.org/10.3310/hta14suppl2/07 Reuse Unless indicated otherwise, fulltext items are protected by copyright with all rights reserved. The copyright exception in section 29 of the Copyright, Designs and Patents Act 1988 allows the making of a single copy solely for the purpose of non-commercial research or private study within the limits of fair dealing. The publisher or other rights-holder may allow further reproduction and re-use of this version - refer to the White Rose Research Online record for this item. Where records identify the publisher as the copyright holder, users can verify any specific terms of use on the publisher’s website. Takedown If you consider content in White Rose Research Online to be in breach of UK law, please notify us by emailing [email protected] including the URL of the record and the reason for the withdrawal request. [email protected] https://eprints.whiterose.ac.uk/ Health Technology Assessment 2010; Vol. 14: Suppl. 2 Single Technology Appraisals A supplement to Health Technology
    [Show full text]
  • Outcomes of Electrically Stimulated Gracilis Neosphincter Surgery ISSN 1366-5278 Feedback Your Views About This Report
    Health Technology Assessment Health Technology Health Technology Assessment 2005; Vol. 9: No. 28 2005; 9: No. 28 Vol. Outcomes of electrically stimulated gracilis neosphincter surgery Outcomes of electrically stimulated gracilis neosphincter surgery T Tillin, M Chambers and R Feldman Feedback The HTA Programme and the authors would like to know your views about this report. The Correspondence Page on the HTA website (http://www.ncchta.org) is a convenient way to publish your comments. If you prefer, you can send your comments to the address below, telling us whether you would like us to transfer them to the website. We look forward to hearing from you. July 2005 The National Coordinating Centre for Health Technology Assessment, Mailpoint 728, Boldrewood, Health Technology Assessment University of Southampton, NHS R&D HTA Programme Southampton, SO16 7PX, UK. HTA Fax: +44 (0) 23 8059 5639 Email: [email protected] http://www.ncchta.org ISSN 1366-5278 HTA How to obtain copies of this and other HTA Programme reports. An electronic version of this publication, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (http://www.hta.ac.uk). A fully searchable CD-ROM is also available (see below). Printed copies of HTA monographs cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our Despatch Agents. Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.
    [Show full text]
  • Health Benefits of Antiviral Therapy for Mild Chronic Hepatitis C: Randomised Controlled Trial and Economic Evaluation
    Health Technology Assessment Health Technology Health Technology Assessment 2006; Vol. 10: No. 21 2006; 10: No. 21 Vol. Health benefits of antiviral therapy for mild chronic hepatitis C Health benefits of antiviral therapy for mild chronic hepatitis C: randomised controlled trial and economic evaluation M Wright, R Grieve, J Roberts, J Main and HC Thomas on behalf of the UK Mild Hepatitis C Feedback Trial Investigators The HTA Programme and the authors would like to know your views about this report. The Correspondence Page on the HTA website (http://www.hta.ac.uk) is a convenient way to publish your comments. If you prefer, you can send your comments to the address below, telling us whether you would like us to transfer them to the website. We look forward to hearing from you. July 2006 The National Coordinating Centre for Health Technology Assessment, Mailpoint 728, Boldrewood, Health Technology Assessment University of Southampton, NHS R&D HTA Programme Southampton, SO16 7PX, UK. HTA Fax: +44 (0) 23 8059 5639 Email: [email protected] http://www.hta.ac.uk ISSN 1366-5278 HTA How to obtain copies of this and other HTA Programme reports. An electronic version of this publication, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (http://www.hta.ac.uk). A fully searchable CD-ROM is also available (see below). Printed copies of HTA monographs cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our Despatch Agents. Non-UK purchasers will have to pay a small fee for post and packing.
    [Show full text]
  • Monitoring Blood Glucose Control in Diabetes Mellitus: a Systematic Review
    Health Technology Assessment 2000; Vol. 4: No. 12 Review Monitoring blood glucose control in diabetes mellitus: a systematic review S Coster MC Gulliford PT Seed JK Powrie R Swaminathan Health Technology Assessment NHS R&D HTA Programme HTA Standing Group on Health Technology Current members Chair: Professor John Gabbay Dr Jeremy Metters Dr John Tripp Professor Kent Woods Director, Wessex Institute Deputy Chief Medical Officer, Senior Lecturer in Child Professor of Therapeutics, for Health Research Department of Health Health, Royal Devon and Exeter University of Leicester & Development Professor Maggie Pearson Healthcare NHS Trust Regional Director of R&D, Professor Sir John Professor Tom Walley Professor Martin Buxton NHS Executive North West Grimley Evans Director, Director & Professor of Professor of Clinical Geratology, Mr Hugh Ross Prescribing Research Group, Health Economics, Radcliffe Infirmary, Chief Executive, University of Liverpool Health Economics Oxford The United Bristol Research Group, Healthcare NHS Trust Dr Julie Woodin Brunel University Dr Tony Hope Professor Trevor Sheldon Clinical Reader in Medicine, Chief Executive, Professor Shah Ebrahim Joint Director, York Health Nuffield Department of Nottingham Health Authority Professor of Epidemiology Policy Group, University of York Clinical Medicine, of Ageing, University of Bristol University of Oxford Professor Mike Smith Professor Francis H Creed Faculty Dean of Research Professor of Professor Richard Lilford for Medicine, Dentistry, Psychological Medicine, Regional Director
    [Show full text]